Literature DB >> 2041980

Antibodies to arthritis-associated microbes in inflammatory joint diseases.

O Mäki-Ikola1, M K Viljanen, S Tiitinen, P Toivanen, K Granfors.   

Abstract

IgM, IgG and IgA class antibodies against Yersinia, Salmonella, Campylobacter and Borrelia were determined by enzyme-linked immunosorbent assay (ELISA) in a group of 340 unselected patients with a recent inflammatory joint disease. The control group consisted of 340 and 100 healthy blood donors using Borrelia-ELISA and other ELISAs, respectively. Of all the patients, 27.4% had increased antibody levels against at least one of the microbes tested. The prevalence of positive antibody levels was highest in Yersinia antibodies (17.9%). The corresponding figures for Salmonella, Campylobacter and Borrelia were 7.0, 6.2 and 1.8%, respectively. Patients with entero-arthritis or clinically typical reactive arthritis who had not had gastrointestinal or urogenital symptoms previously had the highest prevalence of the microbial antibodies (67.6 and 40.7%, respectively). These findings indicate that arthritis may often have a reactive etiopathogenesis without recognized gastrointestinal infection, emphasizing the importance of microbial serology in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041980     DOI: 10.1007/bf02274884

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  The effect of storage of antigen-coated polystyrene microwells on the detection of antibodies against Borrelia burgdorferi by enzyme immunoassay (EIA).

Authors:  M K Viljanen; J Punnonen
Journal:  J Immunol Methods       Date:  1989-11-13       Impact factor: 2.303

3.  Antimicrobial antibodies in patients with a non-specific arthritis.

Authors:  L Palombi; S Mancinelli; M C Marazzi; M Galeazzi; P Pasquini; A Garpodinoff; A Panà
Journal:  Clin Exp Rheumatol       Date:  1989 Nov-Dec       Impact factor: 4.473

4.  Comparison of bacteria with and without plasmid-encoded proteins as antigens for measurement of immunoglobulin M, G, and A antibodies to Yersinia enterocolitica by enzyme-linked immunosorbent assay.

Authors:  K Granfors; R Lahesmaa-Rantala; T H Ståhlberg; A Toivanen
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

Review 5.  Reiter's syndrome and reactive arthritis in perspective.

Authors:  A Keat
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

6.  Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis.

Authors:  K Granfors; S Jalkanen; A A Lindberg; O Mäki-Ikola; R von Essen; R Lahesmaa-Rantala; H Isomäki; R Saario; W J Arnold; A Toivanen
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

7.  Serological diagnosis of salmonella infections by enzyme immunoassay.

Authors:  O Isomäki; R Vuento; K Granfors
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

8.  Follow-up studies of joint complications in yersiniosis.

Authors:  J L Kalliomäki; R Leino
Journal:  Acta Med Scand       Date:  1979

9.  Yersinia antibodies in inflammatory joint diseases.

Authors:  K Granfors; H Isomäki; R von Essen; J Maatela; J L Kalliomäki; A Toivanen
Journal:  Clin Exp Rheumatol       Date:  1983 Jul-Sep       Impact factor: 4.473

10.  Antibacterial antibody pattern in seronegative spondyloarthropathies (SNSA).

Authors:  G Lapadula; M Covelli; R Numo
Journal:  Clin Exp Rheumatol       Date:  1988 Oct-Dec       Impact factor: 4.473

View more
  2 in total

1.  Genetic background of IL-10(-/-) mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype.

Authors:  L S Mansfield; J S Patterson; B R Fierro; A J Murphy; V A Rathinam; J J Kopper; N I Barbu; T J Onifade; J A Bell
Journal:  Microb Pathog       Date:  2008-06-11       Impact factor: 3.738

2.  Incidence of Yersinia enterocolitica antibodies in patients with inflammatory joint diseases.

Authors:  V Tamburrino; R Monno; M A Valenza; R Numo
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.